ursodeoxycholic acid 300 mg | ursizia-300

Ursodeoxycholic Acid 300 mg

Brand Name: Ursizia-300

Composition: Ursodeoxycholic Acid 300 mg

MRP: 4000

Packing: 10×10 Alu/Alu

Table of Contents

Product Overview

Ursizia-300 is a liver-supporting and choleretic medication containing Ursodeoxycholic Acid 300 mg (UDCA). It is widely prescribed for cholestatic liver diseases, gallstone management, and improving bile flow, helping patients maintain liver and digestive health.

Manufactured by Biozia Lifesciences Pvt. Ltd. under WHO-GMP standards, Ursizia-300 is a reliable choice for patients and healthcare providers. It is also a high-demand product for PCD Pharma Franchise partners, especially in gastroenterology and hepatology segments.

Key Benefits of Ursizia-300

    • Supports liver health in chronic liver conditions

    • Helps dissolve small cholesterol gallstones non-surgically

    • Improves bile flow and reduces bile-related discomfort

    • Reduces cholestasis in liver diseases

    • Convenient once or twice daily tablet for patient compliance

    • High-demand PCD franchise product in gastroenterology

Indications for Ursodeoxycholic Acid 300 mg

Ursizia-300 is prescribed for a variety of liver, gallbladder, and bile-related conditions:

    • Primary Biliary Cholangitis (PBC) – A chronic liver disease that blocks bile ducts, leading to bile accumulation (PubMed)

    • Primary Sclerosing Cholangitis (PSC) – Helps in management of cholestasis and bile flow in early stages

    • Gallstone Management – Dissolves small, non-calcified cholesterol gallstones in patients unwilling or unfit for surgery (Drugs.com)

    • Cholestatic Liver Disease – Reduces bile acid toxicity and improves liver function

    • Non-Alcoholic Fatty Liver Disease (NAFLD) – Supports bile secretion and liver enzyme normalization

    • Cirrhosis with Cholestasis – Assists in reducing liver enzyme levels and improving bile flow

    • Post-Liver Transplant – Sometimes used to improve bile drainage in transplant patients

    • Drug-Induced Cholestasis – Helps restore bile flow in certain medication-related liver impairments

Mechanism of Action

Ursodeoxycholic Acid (UDCA) is a hydrophilic bile acid that:

    • Reduces cholesterol absorption and dissolves cholesterol gallstones

    • Protects liver cells by displacing toxic hydrophobic bile acids

    • Improves bile flow from the liver to the intestine, reducing cholestasis (NCBI)

    • Modulates immune response in autoimmune liver diseases like PBC

The combined actions result in hepatoprotection, improved digestion, and symptom relief in bile-related disorders.

Dosage and Administration for Ursizia-300

    • Typical adult dosage: 300 mg to 600 mg per day, divided into 1–2 doses, as prescribed by a doctor

    • Take after meals to reduce stomach irritation

    • Swallow tablets whole; do not crush or chew

    • Course duration depends on the condition (e.g., gallstone dissolution may require months of therapy)

General Health & Recovery Tips

    • Maintain a low-fat diet to reduce gallstone formation

    • Stay hydrated to support bile flow

    • Avoid alcohol and hepatotoxic drugs

    • Regularly monitor liver function tests (LFTs) during therapy

    • Combine with liver-friendly foods like leafy greens, fruits, and whole grains

Myths & Facts About Ursodeoxycholic Acid

Myth: Gallstones always require surgery.
Fact: Small cholesterol gallstones may dissolve naturally with UDCA therapy like Ursizia-300.

Myth: Liver medications instantly cure chronic liver disease.
Fact: UDCA supports liver function and improves bile flow but long-term management and lifestyle changes are essential.

Myth: UDCA is unsafe for long-term use.
Fact: Generally well-tolerated; long-term therapy is safe under medical supervision.

Did You Know?

    • UDCA is naturally present in small amounts in human bile.

    • Ursizia-300 is often used in chronic liver disease management, especially in PBC and NAFLD patients.

    • Long-term bile flow improvement can prevent liver fibrosis progression.

    • Products like Ursizia-300 are popular in PCD pharma franchise networks due to growing awareness of liver health in India.

    • Regular therapy improves quality of life by reducing fatigue, jaundice, and digestive discomfort.

Why Choose Biozia Lifesciences?

At Biozia Lifesciences Pvt. Ltd., we believe that quality healthcare should be affordable and accessible. Our products are:

    • Manufactured in WHO-GMP certified units.

    • Backed by strong quality testing at every stage.

    • Packed securely to maintain potency and shelf life.

    • Trusted by healthcare professionals across India.

We are more than just a pharmaceutical company — we are partners in improving community health.

Why Partner With Us?

    • Monopoly-based franchise rights.

    • Wide product range across antibiotics, nutraceuticals, pain relief, syrups, and more.

    • Attractive packaging and marketing materials (visual aids, brochures, samples).

    • Timely delivery and stock availability.

    • Dedicated business support to help you grow your pharma business.

👉 Contact us today to explore franchise opportunities in your region.

This information is provided for educational purposes only and does not substitute medical advice. Always consult a qualified physician or pharmacist before starting any medication. The use of this product must comply with local regulations. Biozia Lifesciences is not liable for misuse

FAQ

It is used to support liver function, manage bile flow disorders, and dissolve cholesterol gallstones.

Yes, it is best taken after meals to reduce stomach irritation.

Mild nausea, diarrhea, or abdominal discomfort may occur. Severe side effects are rare.

Only under medical supervision. Consult your doctor before use.

Treatment may take 6–12 months, depending on stone size and composition.